A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases

University Hospital, Montpellier500 enrolled

Overview

The consortium will develop a new in vitro diagnostic (IVD) test to screen donated blood for bloodborne infectious pathogens, saving blood banks time and costs required for analysis of mandatory pathogens. The IVD test is a multiplex immunoassay that simultaneously screens for six bloodborne infectious diseases per blood sample. In this project, a mix of diagnostic protein markers will be developed and validated to lowdown an IVD test ready for commercial scale-up and CE-IVD certification.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

HIV Viral Hepatitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: \- Samples having been tested positive or negative for the serological markers explored in the study Exclusion criteria: \- to refuse to participate to the study

Locations (1)

Uhmontpellier

Montpellier, France

RECRUITING

Outcomes

Primary Outcomes

Number of Analytical performances

Analytical performances

Time frame: day 1

Secondary Outcomes

Number of Field evaluation

Field evaluation

Time frame: day 1

Central Contacts

Edouard TUAILLON, MD, PhD

CONTACT

467 338 469 e-tuaillon@chu-montpellier.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.